Transplantation, AutologousHematopoietic Stem Cell TransplantationStem Cell TransplantationAntineoplastic Combined Chemotherapy ProtocolsPeripheral Blood Stem Cell TransplantationMelphalanMultiple MyelomaCombined Modality TherapyTransplantation, HomologousTransplantation ConditioningTreatment OutcomeCyclophosphamideEtoposideRemission InductionSalvage TherapyDisease-Free SurvivalHodgkin DiseaseVincristineStem CellsLymphoma, Non-HodgkinCytarabineSurvival RateDoxorubicinCarmustineRecurrenceSurvival AnalysisMyeloablative AgonistsBone Marrow TransplantationHematopoietic Stem Cell MobilizationThiotepaGraft vs Host DiseaseCisplatinPrognosisBone Marrow PurgingAntineoplastic AgentsHematologic NeoplasmsIfosfamideRetrospective StudiesLymphoma, Mantle-CellWhole-Body IrradiationFollow-Up StudiesDexamethasoneChemotherapy, AdjuvantAmyloidosisPrednisoneAntineoplastic Agents, AlkylatingBoronic AcidsHematopoietic Stem CellsBusulfanPyrazinesAntibodies, Monoclonal, Murine-DerivedLymphoma, FollicularGraft SurvivalLymphomaTime FactorsInduction ChemotherapyAntigens, CD34ThalidomideGranulocyte Colony-Stimulating FactorLymphoma, T-Cell, PeripheralAutograftsCarboplatinDrug Administration ScheduleLiver TransplantationLymphoma, Large B-Cell, DiffusePodophyllotoxinLeukapheresisBleomycinMesenchymal Stem Cell TransplantationLeukemia, Myeloid, AcuteMitoxantroneNeoplasm, ResidualMaintenance ChemotherapyNeoplasm Recurrence, LocalTransplantation ChimeraNeoplasm StagingMethotrexateLymphoma, B-CellTissue DonorsCord Blood Stem Cell TransplantationNeutropeniaNeoplasms, Second PrimaryProspective StudiesCell TransplantationLeukemia, Plasma CellBreast NeoplasmsIdarubicinMyelodysplastic SyndromesKidney TransplantationEnteropathy-Associated T-Cell LymphomaEmbryonic Stem CellsFeasibility StudiesClinical Trials as TopicAntibodies, MonoclonalInfusions, SpinalFatal OutcomeVinblastineNeoplasmsBlood Component RemovalLeukemia, Myeloid